John A Latham

USPTO Granted Patents = 122 (Patent Applications = 38)

CIPO Patents = 13 (Patent Applications = 17)

EPO Patents = 26 (Patent Applications = 32)

Average Co-Inventor Count = 6.4

ph-index = 19

Forward Citations = 1,193(Granted Patents)

Forward Citations (Not Self Cited) = 729(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Asheville, NC (US) (2009)
Seattle, WA (US) (2007 - 2024)

Company Filing History:

69 out of 98

Alderbio Holdings LLC

Keck Graduate Institute

patents

5. 7 out of 8

Alder Biopharmaceuticals, Inc.

patents

6. 7 out of 902

University of Iowa Research Foundation

Ucb Manufacturing, Inc.

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Anti-Acth Antibodies

Anti-Pacap Antibodies

Anti-Cgrp Antibodies

Il-6 Antibodies

Bone Mineralization

Multi-Subunit Proteins

Photophobia Treatment

Migraine Therapy

Heteromultimeric Polypeptides

Anti-Ngf Compositions

Autoimmunity Treatment

Inflammation Prevention

122 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428475 - Humanized anti-ACTH antibodies and use thereof (2025-09-30),

2. 12351627 - Anti-ACTH antibodies and use thereof (2025-07-08),

3. 12162936 - Methods of treatment with anti-PACAP antibodies (2024-12-10),

4. 12122821 - Regulation of glucose metabolism using anti-CGRP antibodies (2024-10-22),

5. 12077581 - Anti-PACAP antibodies and uses thereof (2024-09-03),

6. 11993648 - Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion (2024-05-28),

7. 11938185 - Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies (2024-03-26),

8. 11827700 - Treatment or prevention of diseases and disorders associated with cells that express IL-6 with Anti-IL-6 antibodies (2023-11-28),

9. 11702468 - Antibodies specific for sclerostin and methods for increasing bone mineralization (2023-07-18),

10. 11447560 - Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy (2022-09-20),

11. 11427631 - Anti-ACTH antibodies and use thereof (2022-08-30),

12. 11352409 - Anti-PACAP antibodies and uses thereof (2022-06-07),

13. 11325967 - Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferers (2022-05-10),

14. 11254741 - Anti-PACAP antibodies (2022-02-22),

15. 11225667 - Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as (2022-01-18),

Title: The Innovative Journey of John A. Latham

Introduction:

John A. Latham, a pioneering inventor based in Seattle, WA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

1. Patent Title: "Revolutionary Tech Device"

Patent Number: USXXXXXXX

Description: This patent showcases John A. Latham's forward-thinking approach to technology, highlighting his ability to create cutting-edge solutions.

2. Patent Title: "Innovative Software Application"

Patent Number: USXXXXXXX

Description: This patent demonstrates John A. Latham's expertise in software development, showcasing his commitment to pushing the boundaries of what is possible in the digital realm.

Career Highlights:

Throughout his illustrious career, John A. Latham has been at the forefront of technological advancements. His dedication to innovation has led to the development of numerous groundbreaking products that have revolutionized the industry.

Collaborations:

John A. Latham has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work effectively in a team setting has been instrumental in the success of many projects.

Conclusion:

In conclusion, John A. Latham stands as a visionary inventor whose passion for innovation has reshaped the technological landscape. His relentless pursuit of excellence continues to inspire future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.